Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1927)
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
6,081
Price
$18.03
Total Value
$109.64K
Shares Held After
4,927,115
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
3,056
Price
$18.03
Total Value
$55.10K
Shares Held After
1,571,214
% of Holdings
0.2%
CareDx, Inc. (CDNA)
Novack Jeffrey Adam — Secretary and General Counsel
Shares
2,688
Price
$20.68
Total Value
$55.58K
Shares Held After
113,924
% of Holdings
2.3%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
200
Price
$15.58
Total Value
$3.12K
Shares Held After
166,844
% of Holdings
0.1%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
7,800
Price
$14.60
Total Value
$113.88K
Shares Held After
167,044
% of Holdings
4.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
68
Price
$158.11
Total Value
$10.75K
Shares Held After
1,666
% of Holdings
3.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
155
Price
$157.29
Total Value
$24.38K
Shares Held After
1,734
% of Holdings
8.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
121
Price
$156.53
Total Value
$18.94K
Shares Held After
1,889
% of Holdings
6.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
173
Price
$155.48
Total Value
$26.90K
Shares Held After
2,010
% of Holdings
7.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
363
Price
$154.44
Total Value
$56.06K
Shares Held After
2,183
% of Holdings
14.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
120
Price
$153.92
Total Value
$18.47K
Shares Held After
2,546
% of Holdings
4.5%
Spok Holdings, Inc (SPOK)
Woods-Keisling Sharon — Corporate Secretary, Treasurer
Shares
10,000
Price
$11.00
Total Value
$110.04K
Shares Held After
26,036
% of Holdings
27.8%
Ultragenyx Pharmaceutical Inc. (RARE)
Crombez Eric — EVP and Chief Medical Officer
Shares
344
Price
$24.96
Total Value
$8.59K
Shares Held After
111,189
% of Holdings
0.3%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
178
Price
$87.31
Total Value
$15.54K
Shares Held After
2,187,500
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
1,650
Price
$86.43
Total Value
$142.61K
Shares Held After
2,187,678
% of Holdings
0.1%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
1,322
Price
$85.56
Total Value
$113.11K
Shares Held After
2,189,328
% of Holdings
0.1%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
600
Price
$83.78
Total Value
$50.27K
Shares Held After
2,190,650
% of Holdings
0.0%
Axsome Therapeutics, Inc. (AXSM)
Jacobson Mark L. — Chief Operating Officer
Shares
233
Price
$228.18
Total Value
$53.17K
Shares Held After
0
% of Holdings
100.0%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
582
Price
$17.18
Total Value
$10.00K
Shares Held After
37,592
% of Holdings
1.5%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
13,473
Price
$16.58
Total Value
$223.32K
Shares Held After
38,174
% of Holdings
26.1%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$77.37
Total Value
$270.80K
Shares Held After
153,902
% of Holdings
2.2%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
11,333
Price
$77.25
Total Value
$875.47K
Shares Held After
58,555
% of Holdings
16.2%
CYTOKINETICS INC (CYTK)
HENDERSON JOHN T — Director
Shares
20,000
Price
$75.97
Total Value
$1.52M
Shares Held After
75,237
% of Holdings
21.0%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
23,906
Price
$76.87
Total Value
$1.84M
Shares Held After
63,221
% of Holdings
27.4%
CYTOKINETICS INC (CYTK)
WIERENGA WENDELL — Director
Shares
4,032
Price
$75.00
Total Value
$302.40K
Shares Held After
32,637
% of Holdings
11.0%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
50,000
Price
$38.57
Total Value
$1.93M
Shares Held After
4,367
% of Holdings
92.0%
Spero Therapeutics, Inc. (SPRO)
Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
25,240
Price
$2.51
Total Value
$63.35K
Shares Held After
986,851
% of Holdings
2.5%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
722
Price
$206.16
Total Value
$148.85K
Shares Held After
2,382,440
% of Holdings
0.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
116,904
Price
$13.97
Total Value
$1.63M
Shares Held After
744,683
% of Holdings
15.7%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,900
Price
$13.90
Total Value
$54.20K
Shares Held After
627,779
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
787
Price
$30.12
Total Value
$23.70K
Shares Held After
377,723
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
325
Price
$29.56
Total Value
$9.61K
Shares Held After
378,510
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
8,989
Price
$28.28
Total Value
$254.21K
Shares Held After
378,835
% of Holdings
2.3%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
4,803
Price
$27.36
Total Value
$131.41K
Shares Held After
387,824
% of Holdings
1.2%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
705
Price
$30.08
Total Value
$21.21K
Shares Held After
279,356
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
320
Price
$29.56
Total Value
$9.46K
Shares Held After
280,061
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
700
Price
$30.08
Total Value
$21.06K
Shares Held After
385,125
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
5,526
Price
$28.37
Total Value
$156.77K
Shares Held After
280,381
% of Holdings
1.9%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
312
Price
$29.56
Total Value
$9.22K
Shares Held After
385,825
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
5,460
Price
$28.37
Total Value
$154.90K
Shares Held After
386,137
% of Holdings
1.4%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
9,250
Price
$27.50
Total Value
$254.38K
Shares Held After
285,907
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
9,180
Price
$27.50
Total Value
$252.45K
Shares Held After
391,597
% of Holdings
2.3%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
697
Price
$30.08
Total Value
$20.97K
Shares Held After
1,614,993
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
683
Price
$30.08
Total Value
$20.54K
Shares Held After
176,248
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
311
Price
$29.56
Total Value
$9.19K
Shares Held After
1,615,690
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
296
Price
$29.56
Total Value
$8.75K
Shares Held After
176,931
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
5,427
Price
$28.37
Total Value
$153.96K
Shares Held After
1,616,001
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
3,908
Price
$28.29
Total Value
$110.56K
Shares Held After
177,227
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
9,136
Price
$27.50
Total Value
$251.24K
Shares Held After
1,621,428
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
9,030
Price
$27.50
Total Value
$248.32K
Shares Held After
181,135
% of Holdings
4.7%
Showing 1151–1200 of 1927 transactions (page 24 of 39)